(LOSS) EARNINGS PER SHARE (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Earnings Per Share [Abstract]
Net (loss) income attributable to Valeant Pharmaceuticals International, Inc.	$ (866,142)	$ (116,025)	$ 159,559
Basic weighted-average number of common shares outstanding (000s)	320,996	305,446	304,655
Diluted effect of stock options and RSUs (000s) (in shares)	0	0	8,484
Diluted effect of convertible notes (000s) (in shares)	0	0	12,980
Diluted weighted-average number of common shares outstanding (000s)	320,996	305,446	326,119
(Loss) earnings per share attributable to Valeant Pharmaceuticals International, Inc.:
Basic (in dollars per share)	$ (2.70)	$ (0.38)	$ 0.52
Diluted (in dollars per share)	$ (2.70)	$ (0.38)	$ 0.49